Biotech Values

[DewDiligence]

Re: Obesity surgery

>The coverage will be limited to three of the most commonly performed procedures: Roux-en-Y gastric bypass, gastric banding and biliopancreatic diversion with a duodenal switch, Phurrough said.<

Gastric banding, under the LapBand trademark, is the bailiwick of IMDC, the breast-implant company that is being acquired by AGN. It’s purported to be the safest of the various surgery options and is reversible in most cases.